Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03362164 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of HEArt invoLvement in Patients With FABRY Disease

Study acronym: HEAL-FABRY
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv4
  2. Site contact updatedv3
  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Wuerzburg University Hospital
25 trials monitored
See 1 trial at risk
Heart Disease
8,786 trials monitored
See 412 trials at risk
Stroke
3,531 trials monitored
See 153 trials at risk
Chronic Kidney Disease
1,417 trials monitored
See 68 trials at risk
and 1 more disease
This study evaluates predictors for the incidence of arrhythmias and sudden cardiac death as well as terminal heart failure in patients with Fabry disease.
Trial Details
NCT Number NCT03362164
Lead Sponsor Wuerzburg University Hospital
Collaborators: Competence Network Heart Failure, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), St George's, University of London
Conditions
(from sponsor)		 Rare Diseases, Fabry Disease, Fabry Disease, Cardiac Variant, Hypertrophic Cardiomyopathy
Related terms Cardiomyopathy, Hypertrophic, Fabry Disease, Fabry Disease, Cardiac Variant, Fibrosis, Rare Diseases, Renal Insufficiency, Chronic, Stroke
Enrollment 650 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov